White William Richard — SEC Form 4 filings
SEC reporting owner CIK 1778739. 30 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2024-01-23 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 46 legs across 20 filings — 324,356 shares, $9,340,400 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 77.
- Largest priced transaction: sale of 79,446 shares @ $27.19 ($2,160,137) in Akero Therapeutics, Inc., filed 2024-07-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) | Chief Financial Officer | 14 | — | 19 legs · 307,784 sh · $8,503,159 | 37 |
| Disc Medicine, Inc. (IRON) | Director | 12 | — | 27 legs · 16,572 sh · $837,241 | 31 |
| Ventyx Biosciences, Inc. (VTYX) | Director | 4 | — | — | 9 |
Form 4 filings — White William Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 6,212 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 119,120 (derivative) · Disposition to issuer (D): 21,825 (derivative) · Disposition to issuer (D): 15,937 (derivative) | EDGAR |
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 10,179 · Disposition to issuer (D): 47,573 · Disposition to issuer (D): 3,421 (derivative) · Disposition to issuer (D): 5,032 (derivative) · Disposition to issuer (D): 2,328 (derivative) · Disposition to issuer (D): 4,739 (derivative) · +12 more | EDGAR |
| 2025-09-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 659 @ $43.02 | EDGAR |
| 2025-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 890 @ $23.87 | EDGAR |
| 2025-06-20 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 1,634 @ $54.84 | EDGAR |
| 2025-06-13 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,804 @ $53.99 | EDGAR |
| 2025-06-06 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 676 @ $44.88 | EDGAR |
| 2024-12-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 24,300 @ $0 · Grant/award (A): 73,700 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,817 @ $30.79 | EDGAR |
| 2024-12-04 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 1,756 @ $2.65 · Option exercise (M): 201 @ $9.86 · Sale (S): 22 @ $63.49 · Sale (S): 1,762 @ $64.58 · Sale (S): 173 @ $65.33 · Option exercise (M): 1,756 (derivative) @ $0 · +1 more | EDGAR |
| 2024-11-05 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Sale (S): 72 @ $45.68 · Sale (S): 129 @ $46.75 · Option exercise (M): 7,136 @ $45.69 · Sale (S): 1,790 @ $57.59 · Sale (S): 5,346 @ $58.94 · +2 more | EDGAR |
| 2024-10-03 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Sale (S): 32 @ $49.03 · Sale (S): 40 @ $50.45 · Sale (S): 50 @ $51.51 · Sale (S): 79 @ $52.53 · Option exercise (M): 201 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 639 @ $26.18 | EDGAR |
| 2024-09-05 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Option exercise (M): 1,756 @ $2.65 · Sale (S): 1,560 @ $49.43 · Sale (S): 337 @ $50.29 · Sale (S): 50 @ $51.54 · Sale (S): 10 @ $52.28 · +2 more | EDGAR |
| 2024-08-29 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 32,671 @ $7.01 · Sale (S): 32,671 @ $27.21 · Option exercise (M): 24,372 @ $19.87 · Sale (S): 24,372 @ $27.21 · Option exercise (M): 18,116 @ $21.09 · Sale (S): 18,116 @ $27.21 · +6 more | EDGAR |
| 2024-08-05 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Sale (S): 144 @ $43.24 · Sale (S): 57 @ $43.95 · Option exercise (M): 201 (derivative) @ $0 | EDGAR |
| 2024-07-25 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 500 @ $7.01 · Sale (S): 500 @ $28.01 · Option exercise (M): 139,083 @ $7.01 · Sale (S): 59,637 @ $26.71 · Sale (S): 79,446 @ $27.19 · Option exercise (M): 22,272 @ $7.01 · +5 more | EDGAR |
| 2024-07-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 29,803 @ $7.01 · Sale (S): 29,803 @ $28.05 · Sale (S): 5,008 @ $28.05 · Option exercise (M): 29,803 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Sale (S): 18 @ $45.07 · Sale (S): 109 @ $45.92 · Sale (S): 74 @ $46.45 · Option exercise (M): 201 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,831 @ $22.64 | EDGAR |
| 2024-06-07 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 1,756 @ $2.65 · Option exercise (M): 201 @ $9.86 · Sale (S): 107 @ $35.15 · Sale (S): 1,755 @ $36.10 · Sale (S): 95 @ $36.72 · Option exercise (M): 1,756 (derivative) @ $0 · +1 more | EDGAR |
| 2024-05-03 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 201 @ $9.86 · Sale (S): 162 @ $28.52 · Sale (S): 39 @ $29.11 · Option exercise (M): 201 (derivative) @ $0 | EDGAR |
| 2024-04-15 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 1,756 @ $2.65 · Option exercise (M): 804 @ $9.86 · Sale (S): 2,482 @ $31.79 · Sale (S): 78 @ $32.18 · Option exercise (M): 1,756 (derivative) @ $0 · Option exercise (M): 804 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 724 @ $28.33 | EDGAR |
| 2024-01-23 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1778739 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →